Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly

Objective To assess whether informant-reported apneas during sleep (witnessed apneas) in cognitively unimpaired (CU) elderly persons are associated with higher levels of brain tau. Methods From the population-based Mayo Clinic Study of Aging, we identified 292 CU elderly ≥65 years of age with both AV-1451 tau-PET and Pittsburgh compound B (PiB)-PET scans and whose bed partners and close relatives had completed a questionnaire that assessed whether participants had witnessed apneas during sleep. For this cross-sectional analysis, we selected the entorhinal and inferior temporal cortices as our regions of interest (ROIs) because they are highly susceptible to tau accumulation. PET signal was scaled to the cerebellum crus to calculate standardized uptake value ratio (SUVR). We fit linear models to assess the association between regional tau and witnessed apneas while controlling for age, sex, years of education, body mass index, hypertension, hyperlipidemia, diabetes, reduced sleep, excessive daytime sleepiness, and global PiB. Results Forty-three participants (14.7%) were found to have witnessed apneas during sleep. The report of witnessed apneas was associated with higher tau-PET SUVR elevation in our ROIs: 0.049 SUVR (95% confidence interval [CI] 0.010–0.087, p = 0.015) in the entorhinal cortex and 0.037 SUVR (95% CI 0.006–0.067, p = 0.019) in the inferior temporal cortex after controlling for confounders. Conclusion We identified a significant association between witnessed apneas in CU elderly and elevated tau-PET signal in tau-susceptible brain regions. These results suggest a plausible mechanism that could contribute to cognitive impairment and the development of Alzheimer disease. Longitudinal observations are necessary to determine direction of causality.

[1]  David T. Jones,et al.  Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults , 2019, Neurology.

[2]  David T. Jones,et al.  Entorhinal cortex tau, amyloid-&bgr;, cortical thickness and memory performance in non-demented subjects , 2019, Brain : a journal of neurology.

[3]  G. Jean-Louis,et al.  Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes. , 2019, Sleep.

[4]  D. Holtzman,et al.  The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans , 2019, Science.

[5]  A. Fagan,et al.  Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease , 2019, Science Translational Medicine.

[6]  C. Rowe,et al.  Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging. , 2018, Journal of Alzheimer's disease : JAD.

[7]  C. Jack,et al.  Association of Excessive Daytime Sleepiness With Longitudinal &bgr;-Amyloid Accumulation in Elderly Persons Without Dementia , 2018, JAMA neurology.

[8]  Christopher G Schwarz,et al.  Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.

[9]  J. Morris,et al.  Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics , 2018, Annals of neurology.

[10]  K. Yaffe,et al.  Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis , 2017, JAMA neurology.

[11]  Sangyun Jeong,et al.  Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease , 2017, Molecules and cells.

[12]  E. Sforza,et al.  A 7‐year follow‐up study of obstructive sleep apnoea in healthy elderly: The PROOF cohort study , 2017, Respirology.

[13]  N. Mercuri,et al.  Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes , 2017, Sleep.

[14]  C. Jack,et al.  Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults. , 2017, Sleep medicine.

[15]  David T. Jones,et al.  Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.

[16]  Clifford R. Jack,et al.  Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition , 2016, Alzheimer's & dementia.

[17]  W. Jagust,et al.  Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? , 2016, Trends in Neurosciences.

[18]  A. Joshi,et al.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. , 2016, Brain : a journal of neurology.

[19]  M. Morrell,et al.  Sleep disordered breathing at the extremes of age: the elderly , 2016, Breathe.

[20]  Korey Kam,et al.  Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease , 2016, Sleep medicine reviews.

[21]  E. Sforza,et al.  Prevalence and determinants of subjective sleepiness in healthy elderly with unrecognized obstructive sleep apnea. , 2015, Sleep medicine.

[22]  Michael Berk,et al.  Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample , 2015, BMC Geriatrics.

[23]  Shou-En Lu,et al.  Sleep-disordered breathing advances cognitive decline in the elderly , 2015, Neurology.

[24]  Clifford R. Jack,et al.  Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum , 2015, Brain : a journal of neurology.

[25]  S. Ancoli-Israel,et al.  Associations Between Sleep‐Disordered Breathing, Nocturnal Hypoxemia, and Subsequent Cognitive Decline in Older Community‐Dwelling Men: The Osteoporotic Fractures in Men Sleep Study , 2015, Journal of the American Geriatrics Society.

[26]  E. Sforza,et al.  Sleep breathing disorders and cognitive function in the elderly: an 8-year follow-up study. the proof-synapse cohort. , 2015, Sleep.

[27]  Maiken Nedergaard,et al.  Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury , 2014, The Journal of Neuroscience.

[28]  G. Bloom.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. , 2014, JAMA neurology.

[29]  D. Holtzman,et al.  Sleep and Alzheimer disease pathology—a bidirectional relationship , 2014, Nature Reviews Neurology.

[30]  D. Bennett,et al.  Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. , 2013, JAMA neurology.

[31]  A. Yang,et al.  Sleep Apnea and the Risk of Dementia: A Population-Based 5-Year Follow-Up Study in Taiwan , 2013, PloS one.

[32]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[33]  Kevin F. Bieniek,et al.  Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample. , 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[34]  P. Vemuri,et al.  Brain β-amyloid load approaches a plateau , 2013, Neurology.

[35]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[36]  Scott M. Brue,et al.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.

[37]  E G Tangalos,et al.  The incidence of MCI differs by subtype and is higher in men , 2012, Neurology.

[38]  Kannan Ramar,et al.  Updates on definition, consequences, and management of obstructive sleep apnea. , 2011, Mayo Clinic proceedings.

[39]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[40]  Kristine Yaffe,et al.  Sleep disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women , 2010, Alzheimer's & Dementia.

[41]  Seiji Nishino,et al.  Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle , 2009, Science.

[42]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[43]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[44]  R. Chervin.  Epworth sleepiness scale? , 2003, Sleep medicine.

[45]  D. Kripke,et al.  Long-term follow-up of sleep disordered breathing in older adults. , 2001, Sleep medicine.

[46]  E. Bixler,et al.  Effects of age on sleep apnea in men: I. Prevalence and severity. , 1998, American journal of respiratory and critical care medicine.

[47]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[48]  D. Kripke,et al.  Sleep-disordered breathing in community-dwelling elderly. , 1991, Sleep.

[49]  H. Mayberg,et al.  Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging , 1990, Journal of computer assisted tomography.

[50]  Christopher G Schwarz,et al.  Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. , 2018, Brain : a journal of neurology.

[51]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.